Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: a machine learning analysis.

J Cancer Res Clin Oncol · 2026 · PMC12783467 · PMID 41504936

Europe PMC DOI

hedged sentence

0.0770

closest p · 1.5× alpha

0.0770

boldest claim

The sentences

a strong trendp = 0.077so close (0.05 < p ≤ 0.1)

Prior tumor control ≥ 12 months showed a strong trend toward improved OS (β = 2.10, OR 8.20, 95% CI 0.80–165.68, p = 0.077).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.